Aziz Sawaf

All filings by Aziz Sawaf on record concern Theravance Biopharma, Inc. We count 21 filings; the first trade dates from 20 February 2023 and the latest from 23 September 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 24 September 2026 came the latest disclosure, a transaction in Theravance Biopharma, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.